Harila-Saari A - Search Results

1

PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.

Henriksen LT, Harila-Saari A, Ruud E, Abrahamsson J, Pruunsild K, Vaitkeviciene G, Jónsson ÓG, Schmiegelow K, Heyman M, Schrøder H, Albertsen BK; Nordic Society of Paediatric Haematology and Oncology (NOPHO) group. Henriksen LT, et al. Pediatr Blood Cancer. 2015 Mar;62(3):427-33. doi: 10.1002/pbc.25319. Epub 2014 Nov 21. Pediatr Blood Cancer. 2015. PMID: 25418987 Clinical Trial.

2

Brain perfusion after treatment of childhood acute lymphoblastic leukemia.

Harila-Saari AH, Ahonen AK, Vainionpää LK, Pääkkö EL, Pyhtinen J, Himanen AS, Torniainen PJ, Lanning BM. Harila-Saari AH, et al. J Nucl Med. 1997 Jan;38(1):82-8. J Nucl Med. 1997. PMID: 8998157 Free article.

3

Nerve lesions after therapy for childhood acute lymphoblastic leukemia.

Harila-Saari AH, Vainionpää LK, Kovala TT, Tolonen EU, Lanning BM. Harila-Saari AH, et al. Cancer. 1998 Jan 1;82(1):200-7. doi: 10.1002/(sici)1097-0142(19980101)82:1<200::aid-cncr25>3.0.co;2-5. Cancer. 1998. PMID: 9428498

4

A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia.

Harila-Saari AH, Pääkkö EL, Vainionpää LK, Pyhtinen J, Lanning BM. Harila-Saari AH, et al. Cancer. 1998 Dec 15;83(12):2608-17. Cancer. 1998. PMID: 9874469

5

Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.

Harila-Saari AH, Huuskonen UE, Tolonen U, Vainionpää LK, Lanning BM. Harila-Saari AH, et al. Med Pediatr Oncol. 2001 Mar;36(3):345-51. doi: 10.1002/mpo.1084. Med Pediatr Oncol. 2001. PMID: 11241435

6

Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia.

Lehtinen SS, Huuskonen UE, Harila-Saari AH, Tolonen U, Vainionpää LK, Lanning BM. Lehtinen SS, et al. Cancer. 2002 May 1;94(9):2466-73. doi: 10.1002/cncr.10503. Cancer. 2002. PMID: 12015772 Free article.

7

High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.

Niinimäki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Pääkkö EL, Möttönen MI, Lanning M. Niinimäki RA, et al. J Clin Oncol. 2007 Apr 20;25(12):1498-504. doi: 10.1200/JCO.2006.06.2539. J Clin Oncol. 2007. PMID: 17442991

8

Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.

Harila MJ, Winqvist S, Lanning M, Bloigu R, Harila-Saari AH. Harila MJ, et al. Pediatr Blood Cancer. 2009 Aug;53(2):156-61. doi: 10.1002/pbc.21992. Pediatr Blood Cancer. 2009. PMID: 19405135

9

High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia.

Harila MJ, Salo J, Lanning M, Vilkkumaa I, Harila-Saari AH. Harila MJ, et al. Pediatr Blood Cancer. 2010 Aug;55(2):331-6. doi: 10.1002/pbc.22531. Pediatr Blood Cancer. 2010. PMID: 20582965

10

In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia.

Lönnerholm G, Thörn I, Sundström C, Frost BM, Flaegstad T, Heyman M, Jonsson OG, Harila-Saari A, Madsen HO, Porwit A, Schmiegelow K, Söderhäll S, Wesenberg F, Vettenranta K, Larsson R, Forestier E. Lönnerholm G, et al. Leuk Res. 2011 Apr;35(4):472-8. doi: 10.1016/j.leukres.2010.09.001. Epub 2010 Oct 18. Leuk Res. 2011. PMID: 20961616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page